XML 27 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
Subsequent Events (Details) (USD $)
3 Months Ended 0 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Apr. 30, 2015
May 08, 2015
Investor
Subsequent Event [Line Items]        
Revenue from grants $ 698,839us-gaap_RevenueFromGrants $ 575,659us-gaap_RevenueFromGrants    
Subsequent Event [Member] | Asterias Biotherapeutics [Member] | CIRM [Member]        
Subsequent Event [Line Items]        
Revenue from grants     1,062,023us-gaap_RevenueFromGrants
/ dei_LegalEntityAxis
= btx_AsteriasBiotherapeuticsMember
/ us-gaap_MajorCustomersAxis
= btx_CaliforniaInstituteOfRegenerativeMedicineMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
 
Grants receivable     14,300,000us-gaap_GrantsReceivable
/ dei_LegalEntityAxis
= btx_AsteriasBiotherapeuticsMember
/ us-gaap_MajorCustomersAxis
= btx_CaliforniaInstituteOfRegenerativeMedicineMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
 
Subsequent Event [Member] | OncoCyte Corporation [Member]        
Subsequent Event [Line Items]        
Sale of stock, number of shares issued in transaction (in shares)       3,000,000us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Sale of stock, number of shareholders       2btx_NumberOfInvestors
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Sale of stock consideration received       3,300,000us-gaap_SaleOfStockConsiderationReceivedPerTransaction
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Common stock purchased in exchange for cancelation of indebtedness (in shares)       3,000,000us-gaap_DebtConversionConvertedInstrumentSharesIssued1
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Common stock purchased in exchange for cancelation of indebtedness, value       3,300,000us-gaap_DebtConversionConvertedInstrumentAmount1
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Subsequent Event [Member] | OncoCyte Corporation [Member] | George Karfunkel [Member]        
Subsequent Event [Line Items]        
Sale of stock, number of shares issued in transaction (in shares)       1,000,000us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_MajorityShareholderMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Ownership percentage on outstanding common shares (in hundredths)       5.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_MajorityShareholderMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Subsequent Event [Member] | OncoCyte Corporation [Member] | Convertible Promissory Note [Member]        
Subsequent Event [Line Items]        
Common stock purchased in exchange for cancelation of indebtedness, value       $ 3,300,000us-gaap_DebtConversionConvertedInstrumentAmount1
/ us-gaap_DebtInstrumentAxis
= us-gaap_ConvertibleNotesPayableMember
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Debt instrument interest rate (in hundredths)       1.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= us-gaap_ConvertibleNotesPayableMember
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Debt instrument maturity date Nov. 30, 2016      
Debt instrument conversion price (in hundredths)       $ 1.10us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_DebtInstrumentAxis
= us-gaap_ConvertibleNotesPayableMember
/ dei_LegalEntityAxis
= btx_OncocyteCorporationMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember